# EDGAR Filing Document

**Accession Number:** 0001402328
**File Stem:** 0001683168-26-003260
**Filing Date:** 2026-4
**Character Count:** 2403
**Document Hash:** d2ea91dc9669f4131217c8d45cb1247d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-003260.hdr.sgml**: 20260616

**ACCESSION NUMBER**: 0001683168-26-003260

**CONFORMED SUBMISSION TYPE**: DRSLTR

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sunshine Biopharma Inc.
- **CENTRAL INDEX KEY:** 0001402328
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 205566275
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DRSLTR

**BUSINESS ADDRESS:**
- **STREET 1:** 333 LAS OLAS WAY
- **STREET 2:** CU4 SUITE 433
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301
- **BUSINESS PHONE:** 954-330-0684

**MAIL ADDRESS:**
- **STREET 1:** 333 LAS OLAS WAY
- **STREET 2:** CU4 SUITE 433
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sunshine Biopharma, Inc
- **DATE OF NAME CHANGE:** 20091102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mountain West Business Solutions, Inc
- **DATE OF NAME CHANGE:** 20071030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** mountain west business solutions,inc
- **DATE OF NAME CHANGE:** 20070607

**Sunshine Biopharma Inc.**

333 Las Olas Way, CU4 Suite 433

Fort Lauderdale, FL 33301

April 28, 2026

**<u>CONFIDENTIAL SUBMISSION VIA EDGAR</u>**

Draft Registration Statement

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Sunshine Biopharma Inc.** |
|  | **Draft Registration Statement on Form S-1** |

---

Ladies and Gentlemen:

Sunshine Biopharma Inc. (the "Company") is hereby submitting a draft registration statement on Form S-1 to the staff of the Securities and Exchange Commission for confidential non-public review.

The Company hereby confirms that it will publicly file its registration statement and nonpublic draft submission such that they are publicly available on the EDGAR system at least two business days prior to any requested effective time and date.

Kindly address any comments or questions that you have concerning this letter or the draft submission to our counsel, Jeff Cahlon at 212-398-2742 or jcahlon@srfc.law.

Sincerely,

*<u>/s/ Dr. Steve N. Slilaty</u>*

Dr. Steve N. Slilaty

Chief Executive Officer